Dejah Thomas Email & Phone Number

Developed assays for preclinical readouts that contributed to FDA approval processes. This involved experiment planning, defining the assay's purpose—such as cell type identification and functional analysis—and selecting appropriate controls while refining sample preparation to ensure optimal readouts. I also generated staining protocols, notably for a project involving 20-color readouts to study the function of T effector cells versus T regulatory cells in response to a specific antigen. Furthermore, I devised a gating strategy adaptable to different sample sets, allowing for precise and criteria-based analysis.

Maryland, United States

Federal contractor for FDA (Food and Drug Administration)Managed comprehensive data collection and developed analysis plans for ongoing clinical trials, ensuring the integrity and accuracy of all data. I played a pivotal role in crafting clinical trial protocols and manuscripts, providing critical input for their execution and reporting. My responsibilities included resolving protocol-related issues at assigned investigator sites, and working closely with study team members to set up, conduct, and close out clinical trials. I ensured strict adherence to regulatory guidelines and collaborated effectively with stakeholders to drive successful trial outcomes, contributing to advancements in medical research and patient care.

Maryland, United States

A cell therapy company dedicated to the discovery, development and commercialization of therapeutics that advance patient care and treat life threatening diseases worldwide.

United States

Global contract research organization providing comprehensive, integrated drug development, laboratory and life cycle management services.

Baltimore, Maryland, United States

Program Supporting the Department of Homeland Security’s comprehensive strategy for countering terrorism.

South Carolina, United States

NIH established IDeA Networks of Biomedical Research Excellence 1890 Land Grant Program